Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNWGD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,899
Award facts
- Contract value 100% obligated
- $35,898.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors with a ceiling value of $35,898.66. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat eczema, asthma, and other allergic conditions, making this pharmaceutical supply critical for military and veteran healthcare systems supported by DLA.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains. The company's proven capability to compete and perform under DLA contracts positions it as a critical supplier for military healthcare procurement needs, supplying everything from specialty medications and vaccines to medical devices and test kits across the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FNWGD?
SPE2DB25FNWGD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FNWGD worth?
The government has obligated $35,899 on SPE2DB25FNWGD.
Is contract SPE2DB25FNWGD an order under another contract?
Yes. SPE2DB25FNWGD is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWGD competed?
The extent of competition for SPE2DB25FNWGD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award